Bank of New York Mellon’s Prelude Therapeutics PRLD Stock Holding History

Bank of New York Mellon’s Portfolio PRLD Stock Details PRLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$363K	Buy	+68,187	New	+$297K	﹤0.01%	3902
2025 Q2	–	Sell	-28,613	Closed	-$22K	–	4237
2025 Q1	$22K	Hold	28,613	–	–	﹤0.01%	4086
2024 Q4	$36.5K	Hold	28,613	–	–	﹤0.01%	4092
2024 Q3	$59.2K	Sell	28,613 -7,663	-21%	-$35.5K	﹤0.01%	4037
2024 Q2	$138K	Sell	36,276 -3,792	-9%	-$15.4K	﹤0.01%	4000
2024 Q1	$190K	Sell	40,068 -10,532	-21%	-$41K	﹤0.01%	3947
2023 Q4	$216K	Buy	50,600 +17,718	+54%	+$53.9K	﹤0.01%	3927
2023 Q3	$102K	Buy	32,882 +2,066	+7%	+$7.75K	﹤0.01%	4077
2023 Q2	$139K	Buy	+30,816	New	+$184K	﹤0.01%	4048
2023 Q1	–	Sell	-28,879	Closed	-$174K	–	4431
2022 Q4	$174K	Sell	28,879 -300	-1%	-$1.92K	﹤0.01%	4011
2022 Q3	$193K	Sell	29,179 -10	-0%	-$67	﹤0.01%	4032
2022 Q2	$153K	Sell	29,189 -30,631	-51%	-$156K	﹤0.01%	4142
2022 Q1	$412K	Buy	59,820 +2,144	+4%	+$19.6K	﹤0.01%	3828
2021 Q4	$718K	Buy	57,676 +23,364	+68%	+$380K	﹤0.01%	3576
2021 Q3	$1.07M	Buy	34,312 +4,058	+13%	+$131K	﹤0.01%	3352
2021 Q2	$866K	Sell	30,254 -782	-3%	-$27.8K	﹤0.01%	3505
2021 Q1	$1.34M	Buy	31,036 +63	+0.2%	+$4.18K	﹤0.01%	3165
2020 Q4	$2.22M	Buy	+30,973	New	+$1.54M	﹤0.01%	2785

Other funds holding PRLD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Bank of New York Mellon's PRLD Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in Prelude Therapeutics (PRLD) in Q2 2026: 68,187 shares worth $363K. The stake represents ﹤0.01% of the portfolio and ranks #3902 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in PRLD as recently as Q1 2025.

Bank of New York Mellon first reported a position in PRLD in Q4 2020 and has held it in 18 quarters since. The position peaked at $2.22M in Q4 2020. 17 funds tracked by Wall St. Rank hold PRLD as of Q2 2026.

Bank of New York Mellon held 68,187 shares of Prelude Therapeutics worth $363K as of Q2 2026.
Prelude Therapeutics was a new Bank of New York Mellon position in Q2 2026.
Prelude Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3902 holding.
Bank of New York Mellon first reported a position in Prelude Therapeutics in Q4 2020 and has held it in 18 quarters since.
Bank of New York Mellon's Prelude Therapeutics position peaked at $2.22M in Q4 2020.
17 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.